Find a Doctor

Sylvain Thepot

Université D'angers
Male

Bio


Sylvain Thepot is in Angers, France. They have been an author on 48 peer reviewed articles and participated in 5 clinical trials in the past 15 years.

Contact

Angers, FR

Latest Advances


This doctor has not participated in any recent research.

Clinical Trials


Clinical Trial
  • Status: Recruiting
  • Phase: Phase 1/Phase 2
  • Intervention Type: Drug
  • Participants: 65
  • Start Date: April 29, 2020
CPX-351 in Higher Risk Myelodysplastic Syndromes: a Phase I/ II Study as First Line or After Hypomethylating-agents Failure
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 2
  • Intervention Type: Drug
  • Participants: 68
  • Start Date: April 2, 2019
A Single-arm Phase II Multicenter Study of IDH2 (AG-221) Inhibitor in Patients With IDH2 Mutated Myelodysplastic Syndrome
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 2
  • Intervention Type: Drug
  • Participants: 40
  • Start Date: November 2018
Guadecitabine SGI-110 and Donor Lymphocyte Infusions (Dli) After Allogeneic Stem Cell Transplantation (Allo Sct) in Very High Risk MDS or AML Patients

All Publications
View All


Publication
Conference
  • Sponsor: American Society of Hematology (ASH)
  • Event Name: American Society of Hematology Annual Meeting and Exposition 2020
  • Published —
Decitabine Versus Hydroxyurea for Advanced Proliferative CMML: Results of the Emsco Randomized Phase 3 Dacota Trial
Publication
Conference
  • Sponsor: American Society of Hematology (ASH)
  • Event Name: American Society of Hematology Annual Meeting and Exposition 2020
  • Published —
Phase 3 Study of Lenalidomide (LEN) Vs Placebo in Non-Transfusion Dependent (TD) Low Risk Del(5q) MDS Patients - Interim Analysis of the European Sintra-REV Trial

Contact

Angers, FR

Insurance

Contact them to find out if they accept your insurance plan.